Ablation of a site of progression with stereotactic body radiation therapy extends sunitinib treatment from 14 to 22 months

Christopher Straka, D. W Nathan Kim, Robert D. Timmerman, Ivan Pedrosa, Corbin Jacobs, James Brugarolas

Research output: Contribution to journal › Article › peer-review

26 Scopus citations